According to the status of biomarkers including estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2), patients with breast cancer were classified into groups of luminal A, luminal B, HER-2 positive and triple negative [3]. Here, ERBB2 is linked to breast cancer.